American Century Companies Inc. boosted its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 228.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 247,906 shares of the medical research company’s stock after acquiring an additional 172,484 shares during the quarter. American Century Companies Inc.’s holdings in Thermo Fisher Scientific were worth $47,072,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Huntington National Bank grew its position in Thermo Fisher Scientific by 7.0% in the 4th quarter. Huntington National Bank now owns 209,069 shares of the medical research company’s stock valued at $39,698,000 after purchasing an additional 13,721 shares during the period. Dowling & Yahnke LLC lifted its stake in Thermo Fisher Scientific by 2.9% during the 4th quarter. Dowling & Yahnke LLC now owns 11,240 shares of the medical research company’s stock valued at $2,134,000 after acquiring an additional 314 shares in the last quarter. Public Employees Retirement Association of Colorado lifted its stake in Thermo Fisher Scientific by 20.4% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 481,923 shares of the medical research company’s stock valued at $91,508,000 after acquiring an additional 81,537 shares in the last quarter. Everence Capital Management Inc. lifted its stake in Thermo Fisher Scientific by 3.5% during the 4th quarter. Everence Capital Management Inc. now owns 11,629 shares of the medical research company’s stock valued at $2,208,000 after acquiring an additional 394 shares in the last quarter. Finally, CI Investments Inc. lifted its stake in Thermo Fisher Scientific by 3.3% during the 4th quarter. CI Investments Inc. now owns 669,942 shares of the medical research company’s stock valued at $127,209,000 after acquiring an additional 21,697 shares in the last quarter. 86.31% of the stock is owned by institutional investors and hedge funds.

In other news, CFO Stephen Williamson sold 5,000 shares of Thermo Fisher Scientific stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $209.26, for a total transaction of $1,046,300.00. Following the sale, the chief financial officer now directly owns 30,741 shares in the company, valued at approximately $6,432,861.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Patrick M. Durbin sold 6,000 shares of Thermo Fisher Scientific stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $217.55, for a total value of $1,305,300.00. The disclosure for this sale can be found here. Insiders have sold a total of 144,327 shares of company stock worth $28,680,042 over the last quarter. Company insiders own 0.49% of the company’s stock.

TMO has been the topic of several recent analyst reports. Bank of America raised their price objective on Thermo Fisher Scientific from $235.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday, February 1st. BTIG Research initiated coverage on Thermo Fisher Scientific in a research note on Friday, January 5th. They set a “buy” rating and a $230.00 price objective on the stock. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $215.00 price objective on the stock in a research note on Tuesday, October 31st. Leerink Swann restated a “buy” rating on shares of Thermo Fisher Scientific in a research note on Monday, October 30th. Finally, Deutsche Bank set a $226.00 price objective on Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Thursday, October 26th. Two research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $220.50.

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) opened at $200.18 on Monday. The company has a market capitalization of $80,271.17, a price-to-earnings ratio of 35.75, a PEG ratio of 1.47 and a beta of 1.11. Thermo Fisher Scientific Inc. has a 52 week low of $151.74 and a 52 week high of $226.44. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.92 and a current ratio of 1.35.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, January 31st. The medical research company reported $2.79 EPS for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.13. The company had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $5.72 billion. Thermo Fisher Scientific had a return on equity of 16.01% and a net margin of 10.64%. The business’s revenue for the quarter was up 22.1% compared to the same quarter last year. During the same period in the previous year, the business posted $2.41 EPS. research analysts predict that Thermo Fisher Scientific Inc. will post 10.81 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Stockholders of record on Thursday, March 15th will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.34%. This is a boost from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Wednesday, March 14th. Thermo Fisher Scientific’s payout ratio is presently 10.71%.

TRADEMARK VIOLATION NOTICE: “American Century Companies Inc. Boosts Position in Thermo Fisher Scientific Inc. (TMO)” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2018/02/12/american-century-companies-inc-boosts-position-in-thermo-fisher-scientific-inc-tmo.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.